Quince Therapeutics Inc QNCX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:27 PM EDT
0.87quote price arrow down-0.04 (-4.3956%)
Volume
2,592
Close
0.91quote price arrow down-0.0097 (-1.0547%)
Volume
238,518
52 week range
0.84 - 1.74
Loading...
  • Open0.90
  • Day High1.01
  • Day Low0.8996
  • Prev Close0.9197
  • 52 Week High1.74
  • 52 Week High Date05/22/23
  • 52 Week Low0.84
  • 52 Week Low Date11/20/23

Key Stats

  • Market Cap39.326M
  • Shares Out43.22M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-13.33

KEY STATS

  • Open0.90
  • Day High1.01
  • Day Low0.8996
  • Prev Close0.9197
  • 52 Week High1.74
  • 52 Week High Date05/22/23
  • 52 Week Low0.84
  • 52 Week Low Date11/20/23
  • Market Cap39.326M
  • Shares Out43.22M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-13.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.76
  • P/E (TTM)-1.20
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-28.331M
  • ROE (TTM)-33.81%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)15.78%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Quince Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Quince Therapeutics, Inc. is a late-stage biotechnology company. The Company is engaged in unlocking the patient’s own biology to deliver life-changing therapeutics to those living with rare diseases. Its proprietary autologous intracellular drug encapsulation (AIDE) technology platform is a drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The Company’s Phase III lead asset, EryDex, leverages its...
David Lamond
Independent Chairman of the Board
Dirk Thye M.D.
Chief Executive Officer, Director
Charles Ryan Ph.D.
President
Brendan Hannah
Chief Operating Officer, Chief Business Officer, Principal Financial Officer and Principal Accounting
Address
601 Gateway Boulevard, Suite 1250
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
CKPT
Checkpoint Therapeutics Inc
1.56+0.02+1.30%
TCRT
Alaunos Therapeutics Inc
1.28+0.01+1.18%
EYEN
Eyenovia Inc
0.8263+0.0106+1.2995%
UNCY
Unicycive Therapeutics Inc
1.09UNCHUNCH
IMRX
Immuneering Corp
1.60+0.01+0.63%